Soleno Therapeutics Inc (SLNO)
51.12 +0.98 (+1.95%) 11:55 ET [NASDAQ]
51.08 x 21 51.35 x 6
Realtime by (Cboe BZX)
51.08 x 21 51.35 x 6
Realtime 50.50 +0.36 (+0.72%) 09:30 ET
for Tue, Mar 25th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 87,928 | 169,681 | 14,602 | 21,304 | 49,224 |
| Marketable Securities | 203,509 | N/A | N/A | N/A | N/A |
| TOTAL | $293,889 | $171,358 | $15,647 | $22,422 | $50,243 |
| Non-Current Assets | |||||
| PPE Net | 186 | 12 | 26 | 33 | 19 |
| Investments And Advances | 27,211 | 0 | 0 | 0 | 0 |
| Intangibles | 6,805 | 8,749 | 10,693 | 12,637 | 14,581 |
| Other Non-Current Assets | 2,881 | 572 | 131 | 461 | 139 |
| TOTAL | $37,083 | $9,333 | $10,850 | $13,131 | $14,739 |
| Total Assets | $330,972 | $180,691 | $26,497 | $35,553 | $64,982 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,882 | 3,149 | 1,777 | 3,254 | 3,489 |
| Accrued Expenses | 6,602 | 6,528 | 4,897 | 4,148 | 4,794 |
| Other current liabilities | 2,737 | 1,555 | 484 | 323 | 196 |
| TOTAL | $18,747 | $11,505 | $7,313 | $8,007 | $8,618 |
| Non-Current Liabilities | |||||
| aiOther Non-Current Liabilities | 67,112 | 11,679 | 8,836 | 9,753 | 10,817 |
| TOTAL | $67,112 | $11,679 | $8,836 | $9,753 | $10,817 |
| Total Liabilities | $85,859 | $23,184 | $16,149 | $17,760 | $19,435 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 45,857 | 32,461 | 8,169 | 5,342 | 5,318 |
| Common Shares | 46 | 32 | 8 | 80 | 80 |
| Retained earnings | -452,260 | -276,410 | -237,422 | -213,355 | -182,445 |
| Other shareholders' equity | 361 | 0 | 0 | 0 | 0 |
| TOTAL | $245,113 | $157,507 | $10,348 | $17,793 | $45,547 |
| Total Liabilities And Equity | $330,972 | $180,691 | $26,497 | $35,553 | $64,982 |